Sign in or Register   Sign in or Register
  |  

Mouse Anti-BICD2 Recombinant Antibody (CBYY-0560) (CBMAB-0563-YY)

This product is mouse antibody that recognizes BICD2. The antibody CBYY-0560 can be used for immunoassay techniques such as: IP, WB
See all BICD2 antibodies

Summary

Host Animal
Mouse
Specificity
Human, Rat
Clone
CBYY-0560
Antibody Isotype
IgG1
Application
IP, WB

Basic Information

Immunogen
Recombinant protein encompassing a sequence within the N-terminus region of human BICD2.
Host Species
Mouse
Specificity
Human, Rat
Antibody Isotype
IgG1
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.
ApplicationNote
WB1:500-1:3,000
IP1:100-1:500

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Liquid
Buffer
PBS
Preservative
None
Concentration
1 mg/ml
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

Full Name
BICD Cargo Adaptor 2
Introduction
This gene is one of two human homologs of Drosophila bicaudal-D and a member of the Bicoid family. It has been implicated in dynein-mediated, minus end-directed motility along microtubules. It has also been reported to be a phosphorylation target of NIMA related kinase 8. Two alternative splice variants have been described.
Entrez Gene ID
UniProt ID
Alternative Names
BICD Cargo Adaptor 2; Bic-D 2; Cytoskeleton-Like Bicaudal D Protein Homolog 2; Bicaudal D Homolog 2 (Drosophila); Homolog Of Drosophila Bicaudal D; Protein Bicaudal D Homolog 2;
Function
Acts as an adapter protein linking the dynein motor complex to various cargos and converts dynein from a non-processive to a highly processive motor in the presence of dynactin. Facilitates and stabilizes the interaction between dynein and dynactin and activates dynein processivity (the ability to move along a microtubule for a long distance without falling off the track) (By similarity).
Facilitates the binding of RAB6A to the Golgi by stabilizing its GTP-bound form. Regulates coat complex coatomer protein I (COPI)-independent Golgi-endoplasmic reticulum transport via its interaction with RAB6A and recruitment of the dynein-dynactin motor complex (PubMed:25962623).
Contributes to nuclear and centrosomal positioning prior to mitotic entry through regulation of both dynein and kinesin-1. During G2 phase of the cell cycle, associates with RANBP2 at the nuclear pores and recruits dynein and dynactin to the nuclear envelope to ensure proper positioning of the nucleus relative to centrosomes prior to the onset of mitosis (By similarity).
Biological Process
Centrosome localization Source: UniProtKB
Microtubule anchoring at microtubule organizing center Source: BHF-UCL
Microtubule-based movement Source: GO_Central
Minus-end-directed organelle transport along microtubule Source: BHF-UCL
mRNA transport Source: UniProtKB-KW
Protein localization to Golgi apparatus Source: UniProtKB
Protein localization to organelle Source: GO_Central
Protein transport Source: UniProtKB-KW
Regulation of microtubule cytoskeleton organization Source: ARUK-UCL
Retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum Source: UniProtKB
Cellular Location
Golgi apparatus; Cytoskeleton; Cytoplasm; Nucleus envelope; Nuclear pore complex. In interphase cells mainly localizes to the Golgi complex and colocalizes with dynactin at microtubule plus ends (By similarity). Localizes to the nuclear envelope and cytoplasmic stacks of nuclear pore complex known as annulate lamellae in a RANBP2-dependent manner during G2 phase of the cell cycle (PubMed:20386726).
Involvement in disease
Spinal muscular atrophy, lower extremity-predominant 2A, childhood onset, autosomal dominant (SMALED2A): An autosomal dominant form of spinal muscular atrophy characterized by early-childhood onset of muscle weakness and atrophy predominantly affecting the proximal and distal muscles of the lower extremity, although some patients may show upper extremity involvement. The disorder results in delayed walking, waddling gait, difficulty walking, and loss of distal reflexes. Some patients may have foot deformities or hyperlordosis, and some show mild upper motor signs, such as spasticity. Sensation, bulbar function, and cognitive function are preserved. The disorder shows very slow progression throughout life.
Spinal muscular atrophy, lower extremity-predominant, 2B, prenatal onset, autosomal dominant (SMALED2B): An autosomal dominant neuromuscular disorder characterized by decreased fetal movements, fractures in utero, severe congenital joint contractures, arthrogryposis multiplex congenita, severe hypotonia, muscle atrophy, and respiratory insufficiency and failure due to muscle weakness. Some patients may have dysmorphic facial features and/or abnormalities on brain imaging. Death in early childhood may occur.
PTM
Phosphorylated by NEK9 in vitro.
Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Have you used Mouse Anti-BICD2 Recombinant Antibody (CBYY-0560)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare